2Spencer F A, Emery C, Lessard D,et al. The Worcester venous tbrombo- embolism study:a population - based study of the clinical epidemiology of venous thromboembolism[ J]. J Gen Intern Med ,2006,21 (7) :792 - 727. 被引量：1
3Pinto D J, Smahheer J M, Cheney D L,et al. FactorXa lnhibitors:next - Generation Antithrombotic Agents [ J ]. J Med Chem, 2010,53 ( 17 ) : 6243 - 6274. 被引量：1
5Alemida L, Falcao A, Vazda Silva M, et al. Effect of nebicapone on the pharmacokineties and pharmacodynamics of warfarin in healthy subljects [ J]. Eur J Clin Pharmacol,2008,64(10) :961. 被引量：1
8A1 Sallami H,Ferguson R, Wilkins G,et al. Bleeding events in patients receiving enoxaparin for the management of non - ST - e|evation acute coronary syndrome at Dunedin Public Hospital[ J]. New Zealand medical journal ,2008,121 ( 1285 ) :87. 被引量：1
4TURPIE A G. New oral anticoagulants in atrial fibril- lation[J]. Eur HeartJ,2008,29:155--165. 被引量：1
5ZIKRIA .J C, ANSEI,L J. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change[J]. Curr Opin Hematol, 2009,16 : 347-- 356. 被引量：1
6KAKKAR A K, BRENNER B, DAHL O E, et al. Ex- tended duration rivaroxaban versus short-tern1 enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomised controlled trial[J ]. Lancet, 2008,372 : 31 - 39. 被引量：1
7Executive Steering Committee on behalf of the ROCK- ET AF Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vita- min K antagonism for prevention of stroke and embol- ism trial in atrial fibrillation: rationale and design of the ROCKET AFStudy[J].Am Heart J,2010,159: 340--347. 被引量：1
8CLELAND J G, COI.ETTA A P, BUGA L, et al. Clinical trials update from the American Heart Asso- ciation Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT[J].EurJ Heart Fail,2011,13:460-- 465. 被引量：1
9CARREIRO J, ANSELL J. Apixaban, an oral direct factor Xa inhibitor: awaiting the verdict[J]. Exp Opin Invest Drugs, 2008,17 : 1937 -- 1945. 被引量：1
10SAMAMA M M, GEROTZIAFAS G T. Newer anti- coagulants in 2009 [ J ]. J Thromb Thrombolysis, 2010,29:92--104. 被引量：1
8Lim CC, Teo BW, Ong PG, et al. Chronic kidney disease, cardio vascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population[J]. Eur J Prey Cardiol, 2014, 5 (23) :33-38. 被引量：1
9Michelson AD. Methods for the measurement of platelet function[J]. Am J Cardiol, 2009,103 (3 Suppl) : 20- 26. 被引量：1
10Differding JA, Underwood SJ, Van PY, et al. First place residenfs competition:trauma induces a hypercoagulable state that is resist- ant to hypothermia as measured by thrombelastogram[J]. Am J Surg, 2011,201(5) :585-589. 被引量：1
